Research
Q&A: Researcher investigates pharmacological approaches to breast cancer prevention
The Brief
- A new thesis by Mattias Hammarström studied whether lower doses of tamoxifen, and its active metabolite endoxifen given directly, could be used as preventive medication.
- The goal is to reduce side effects while still affecting breast tissue in healthy women.
- The source is a Q&A summary; the full findings are only partly described in the excerpt provided.
Why it matters
It explores whether breast cancer prevention drugs could be given at lower doses with fewer side effects, which may matter for women weighing preventive treatment.
Who’s affected
- women considering preventive breast cancer treatment
- clinicians and researchers in breast cancer prevention
- #breast cancer
- #tamoxifen
- #endoxifen
- #cancer prevention
- #thesis
In a new thesis, Mattias Hammarström studied whether lower doses of tamoxifen and also its active metabolite endoxifen for direct administration, as a preventive medication could reduce side effects while still affecting breast tissue in healthy women. The findings suggest that…
Timeline
Medical Xpress publishes Q&A on the thesis
Medical Xpress - latest medical and health news stories
Q&A: Researcher investigates pharmacological approaches to breast cancer prevention